IBRX PEER ANALYSIS

Immunitybio Inc — metric-by-metric comparison with peers and the industry median

IBRXImmunitybio Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

IBRXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	IBRX	CSL	TLX	MSB	Ind. Median
P/E	—	29.96	—	—	18.06
P/B	-10.34●	2.24	6.38	—	3.62
EV/EBITDA	—	10.35●	120.20	—	15.13
P/S	63.81	2.66●	3.24	31.30	10.65

Financial Health
Metric	IBRX	CSL	TLX	MSB	Ind. Median
Current Ratio	6.67●	2.57	1.43	—	5.90
Debt/Equity	-129.3%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	-1.02●	2.22	13.13	—	1.15

Profitability
Metric	IBRX	CSL	TLX	MSB	Ind. Median
Net Margin	-606.2%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	—	7.7%●	-1.8%	-11.3%	-47.5%
ROA	-179.8%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	-515.2%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	IBRX	CSL	TLX	MSB	Ind. Median
Rev. Growth	351.5%	4.8%	56.3%	410.4%●	5.1%
NI Growth	—	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	IBRX	NUVL	HALO	CORT	PTGX	APGE	Ind. Median
P/E	—	—	28.73●	205.02	—	—	18.06
P/B	-10.34●	8.29	45.63	15.39	15.15	7.41	3.62
EV/EBITDA	—	—	18.99●	670.57	—	—	15.13
P/S	63.81	—	6.64●	12.77	134.06	—	10.65

Financial Health
Metric	IBRX	NUVL	HALO	CORT	PTGX	APGE	Ind. Median
Current Ratio	6.67	16.14	2.76	2.86	17.76	32.59●	5.90
Debt/Equity	-129.3%●	—	976.5%	1.5%	1.5%	0.6%	10.9%
NetDebt/EBITDA	-1.02	—	2.93	-23.21●	4.72	3.86	1.15

Profitability
Metric	IBRX	NUVL	HALO	CORT	PTGX	APGE	Ind. Median
Net Margin	-606.2%	—	23.1%●	6.2%	-154.9%	—	-125.7%
ROE	—	-41.2%	99.4%●	7.3%	-17.1%	-28.5%	-47.5%
ROA	-179.8%	-36.9%	14.3%●	5.8%	-15.9%	-27.4%	-35.8%
EBITDA Margin	-515.2%	—	41.4%●	1.8%	-153.8%	—	-105.8%

Growth + Dividend
Metric	IBRX	NUVL	HALO	CORT	PTGX	APGE	Ind. Median
Rev. Growth	351.5%●	—	39.1%	12.2%	-64.4%	-100.0%	5.1%
NI Growth	—	—	-28.1%●	-64.0%	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on IBRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.